Journal rankings · indicator year 2020
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2020
Oncology journal rankings 2020
238 ranked journals · Subfield in Medicine
Oncology has 238 ranked journals in 2020. The median journal has an OJR of 0.83, below the world average of 1.00, up 0.04 on 2019; Q1 starts at OJR 1.31. The top three are CA A Cancer Journal for Clinicians, Nature Medicine, and The Lancet Oncology.
Ranks and citation indicators: 2020. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2017–2019, the window the 2020 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery962
- Pulmonary and Respiratory Medicine353
- Public Health, Environmental and Occupational Health301
- Cardiology and Cardiovascular Medicine294
- Oncology238
- Infectious Diseases222
- Epidemiology196
- Neurology170
- Physiology163
- Endocrinology, Diabetes and Metabolism161
- Radiology, Nuclear Medicine and Imaging160
- Psychiatry and Mental health140
Show all 42 subfields
- Orthopedics and Sports Medicine123
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology93
- Hematology79
- Obstetrics and Gynecology79
- Rheumatology69
- Nephrology58
- Pharmacology53
- Complementary and alternative medicine51
- Reproductive Medicine48
- Emergency Medicine44
- Geriatrics and Gerontology39
- Otorhinolaryngology37
- Rehabilitation34
- Pathology and Forensic Medicine30
- Hepatology26
- Critical Care and Intensive Care Medicine24
- Genetics22
- Immunology and Allergy22
- Urology14
- Anesthesiology and Pain Medicine13
- Gastroenterology8
- Health Informatics5
- Internal Medicine5
- Family Practice3
- Transplantation3
- Biochemistry1
- Anatomy0
- Microbiology0
238 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2019. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2017–2019, the window the 2020 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2017–2019 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2011 to 2020. | Compare |
|---|---|---|---|---|---|---|---|
1CA A Cancer Journal for CliniciansOAWiley · United States | 127.93Q1 | 634.51 296.90 up from 2019 | 76 | 100% | $4,330 | ||
2Nature MedicineNature Portfolio · United States | 10.65Q1 | 38.45 11.99 up from 2019 | 853 | 58% | $12,690 | ||
3The Lancet OncologyElsevier BV · United Kingdom | 6.73Q1 | 19.71 2.32 up from 2019 | 1,120 | 38% | $7,280 | ||
4Cancer CellCell Press · Netherlands | 6.63Q1 | 24.57 3.67 up from 2019 | 502 | 100% | $10,400 | ||
5Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 6.62Q1 | 19.96 2.60 up from 2019 | 1,605 | 5% | — | ||
6Annals of OncologyElsevier BV · Netherlands | 4.37Q1 | 17.08 5.29 up from 2019 | 1,149 | 100% | $5,080 | ||
7Journal of the National Comprehensive Cancer NetworkNational Comprehensive Cancer | 4.28Q1 | 12.49 1.34 up from 2019 | 495 | 54% | — | ||
8Journal of Hematology & OncologyOABioMed Central · United Kingdom | 4.25Q1 | 18.83 6.40 up from 2019 | 440 | 100% | $4,990 | ||
9JAMA OncologyAmerican Medical Association · United States | 4.10Q1 | 11.77 1.25 up from 2019 | 1,191 | 51% | — | ||
10Journal for ImmunoTherapy of CancerOABMJ · United Kingdom | 3.92Q1 | 14.80 2.94 up from 2019 | 589 | 100% | $2,490 | ||
11Cancer DiscoveryAmerican Association for Cancer Research · United States | 3.50Q1 | 15.61 4.01 up from 2019 | 763 | 36% | — | ||
12Nature Reviews Clinical OncologyNature Portfolio · United Kingdom | 3.38Q1 | 15.30 2.84 up from 2019 | 543 | 32% | — | ||
13Clinical Cancer ResearchAmerican Association for Cancer Research · United States | 3.33Q1 | 11.32 1.23 up from 2019 | 2,088 | 34% | — | ||
14Seminars in Cancer BiologyElsevier BV · United States | 3.02Q1 | 10.46 0.75 down from 2019 | 457 | 31% | $6,060 | ||
15Cancer Immunology ResearchAmerican Association for Cancer Research · United States | 2.95Q1 | 11.21 2.19 up from 2019 | 442 | 14% | — | ||
16JNCI Journal of the National Cancer InstituteOxford University Press · United States | 2.78Q1 | 8.07 0.60 down from 2019 | 571 | 95% | $5,436 | ||
17European Journal of EpidemiologySpringer Science+Business Media · Italy | 2.76Q1 | 8.02 0.83 up from 2019 | 368 | 83% | $3,690 | ||
18npj Precision OncologyOANature Portfolio · United Kingdom | 2.74Q1 | 9.33 0.57 up from 2019 | 99 | 100% | $4,090 | ||
19World Journal of OncologyOAElmer Press Inc. · Canada | 2.54Q1 | 11.49 9.68 up from 2019 | 89 | 100% | — | ||
20Cancer Treatment ReviewsElsevier BV · United Kingdom | 2.53Q1 | 11.56 1.36 up from 2019 | 331 | 47% | $4,910 | ||
21Therapeutic Advances in Medical OncologyOASAGE Publishing · United Kingdom | 2.45Q1 | 9.00 0.77 up from 2019 | 225 | 100% | $2,800 | ||
22European Journal of CancerElsevier BV · United Kingdom | 2.18Q1 | 8.12 1.03 up from 2019 | 1,146 | 39% | $4,270 | ||
23CancerWiley · United States | 2.12Q1 | 5.83 0.39 up from 2019 | 1,761 | 81% | $4,790 | ||
24American Society of Clinical Oncology Educational BookAmerican Society of Clinical Oncology · United States | 2.11Q1 | 7.79 4.38 up from 2019 | 307 | 33% | — | ||
25British Journal of CancerSpringer Nature · United Kingdom | 2.08Q1 | 7.82 1.36 up from 2019 | 1,112 | 100% | $5,190 | ||
26CancersOAMultidisciplinary Digital Publishing Institute · Switzerland | 2.06Q1 | 7.47 0.10 up from 2019 | 2,835 | 100% | $3,499 | ||
27Frontiers in OncologyOAFrontiers Media · Switzerland | 2.05Q1 | 7.27 1.07 up from 2019 | 2,375 | 100% | $3,801 | ||
28OncoImmunologyOALandes Bioscience · United States | 2.03Q1 | 8.52 2.35 up from 2019 | 890 | 100% | $2,913 | ||
29npj Breast CancerOANature Portfolio · United States | 2.03Q1 | 8.44 2.18 up from 2019 | 132 | 100% | $3,790 | ||
30Breast Cancer ResearchOABioMed Central · United Kingdom | 2.00Q1 | 7.42 1.53 up from 2019 | 415 | 100% | $4,190 | ||
31International Journal of CancerWiley · United States | 1.95Q1 | 6.94 1.35 up from 2019 | 1,911 | 83% | $5,030 | ||
32Current Oncology ReportsSpringer Science+Business Media · United States | 1.91Q1 | 6.00 0.96 up from 2019 | 297 | 34% | $5,090 | ||
33Expert Opinion on Investigational DrugsTaylor & Francis · United Kingdom | 1.90Q1 | 5.97 0.59 up from 2019 | 316 | 45% | — | ||
34Current Treatment Options in OncologySpringer Science+Business Media · United States | 1.90Q1 | 5.55 0.67 up from 2019 | 238 | 21% | $4,890 | ||
35Clinical Pharmacology & TherapeuticsWiley · United States | 1.88Q1 | 4.88 0.10 up from 2019 | 975 | 60% | $4,410 | ||
36Archives of Pathology & Laboratory MedicineOAAmerican Medical Association · United States | 1.88Q1 | 4.87 0.27 up from 2019 | 621 | 100% | — | ||
37The OncologistOAAlphaMed Press · United Kingdom | 1.88Q1 | 5.52 0.84 up from 2019 | 983 | 98% | $3,852 | ||
38Cancer Immunology ImmunotherapyOASpringer Science+Business Media · Germany | 1.86Q1 | 7.04 1.14 up from 2019 | 474 | 100% | $4,590 | ||
39Oncology ReviewsOAPAGEPress (Italy) · Switzerland | 1.80Q1 | 4.28 2.95 down from 2019 | 55 | 100% | $2,353 | ||
40JNCI MonographsOxford University Press · United Kingdom | 1.79Q1 | 3.31 1.80 down from 2019 | 52 | 100% | — | ||
41Cancer Biology and MedicineOAChinese Anti-Cancer Association · China | 1.78Q1 | 4.46 1.83 down from 2019 | 156 | 100% | $1,500 | ||
42Molecular Cancer TherapeuticsAmerican Association for Cancer Research · United States | 1.76Q1 | 5.86 0.03 down from 2019 | 787 | 63% | — | ||
43Clinical and Translational GastroenterologyOALippincott Williams & Wilkins · United States | 1.75Q1 | 5.00 0.45 up from 2019 | 241 | 100% | $2,800 | ||
44Seminars in OncologyElsevier BV · United States | 1.73Q1 | 5.61 1.12 up from 2019 | 135 | 25% | $3,550 | ||
45Critical Reviews in Oncology/HematologyElsevier BV · Netherlands | 1.70Q1 | 7.06 0.28 up from 2019 | 541 | 35% | $4,190 | ||
46Cancer ControlOASAGE Publishing · United States | 1.69Q1 | 4.73 0.60 up from 2019 | 143 | 100% | $2,650 | ||
47Annals of Gastroenterological SurgeryOAWiley · Japan | 1.55Q1 | 4.91 1.01 up from 2019 | 178 | 100% | $2,350 | ||
48The Journal of Pathology Clinical ResearchOAWiley · United Kingdom | 1.52Q1 | 5.35 1.38 up from 2019 | 76 | 100% | $3,250 | ||
49ESMO OpenOAElsevier BV · Netherlands | 1.52Q1 | 5.52 0.55 up from 2019 | 312 | 100% | $3,910 | ||
50Chinese Journal of Cancer ResearchOAAME Publishing Company · China | 1.50Q1 | 5.29 0.77 up from 2019 | 213 | 100% | — |
Subfields of Medicine, with Oncology highlighted.
- Surgery962
- Pulmonary and Respiratory Medicine353
- Public Health, Environmental and Occupational Health301
- Cardiology and Cardiovascular Medicine294
- Oncology238
- Infectious Diseases222
- Epidemiology196
- Neurology170
- Physiology163
- Endocrinology, Diabetes and Metabolism161
- Radiology, Nuclear Medicine and Imaging160
- Psychiatry and Mental health140
- Orthopedics and Sports Medicine123
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology93
- Hematology79
- Obstetrics and Gynecology79
- Rheumatology69
- Nephrology58
- Pharmacology53
- Complementary and alternative medicine51
- Reproductive Medicine48
- Emergency Medicine44
- Geriatrics and Gerontology39
- Otorhinolaryngology37
- Rehabilitation34
- Pathology and Forensic Medicine30
- Hepatology26
- Critical Care and Intensive Care Medicine24
- Genetics22
- Immunology and Allergy22
- Urology14
- Anesthesiology and Pain Medicine13
- Gastroenterology8
- Health Informatics5
- Internal Medicine5
- Family Practice3
- Transplantation3
- Biochemistry1
- Anatomy0
- Microbiology0
Journals
Citations made in 2020. Corpus-wide, 86.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
76 additional Oncology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2017–2019, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2020. Publication window: 2017–2019. How these summaries are calculated
- Ranked journals
- 238
- Window papers (baseline)
- 121,890 +15.1% from indicator year 2017
- Median OJR
- 0.829 -1.6% from indicator year 2017
- Rising journals (2025)
- 20
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2017–2019 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 82 | 88 | 96 | 103 | 109 | 120 | 120 | 126 | 127 | 134 | 141 | 150 | 153 | 170 | 179 | 188 | 198 | 213 | 224 | 234 | 238 | 239 | 245 | 245 | 243 | 242 | |
| Window papers (baseline) | 37,821 | 41,430 | 44,340 | 47,392 | 49,058 | 53,111 | 57,002 | 62,106 | 66,087 | 71,283 | 77,009 | 82,075 | 86,189 | 88,804 | 93,912 | 98,660 | 102,921 | 105,891 | 109,984 | 115,044 | 121,890 | 139,666 | 156,942 | 167,602 | 163,907 | 160,807 | |
| Median OJR | 0.55 | 0.62 | 0.70 | 0.799 | 0.805 | 0.831 | 0.85 | 0.90 | 0.94 | 0.93 | 1.010 | 0.95 | 1.006 | 0.974 | 0.972 | 0.967 | 0.832 | 0.84 | 0.82 | 0.79 | 0.829 | 0.830 | 0.77 | 0.750 | 0.73 | 0.748 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.